ProtoPulse · CNAS therapeutic protocols
Data updated 19 Oct 2026, 22:37 · printed from ProtoPulse

BENDAMUSTINUM

Active substance (INN) · ATC L01AA09 · 3 products authorised in Romania

◀ Back

Protocols it appears in

As a medicine of the protocol (in the title) or only mentioned in the text

Code	Protocol	Status	Role	Sublist	GP
L01AA09	BENDAMUSTINUM	In force	medicine of the protocol	C2-P3	NO
L01EL02	ACALABRUTINIBUM	In force	mentioned in the text	C2-P3	NO
L01XC15	OBINUTUZUMAB	In force	mentioned in the text	C2-P3	NO
L01XC37	POLATUZUMAB VEDOTIN	In force	mentioned in the text	C2-P3	NO
L01XE27	IBRUTINIBUM	In force	mentioned in the text	C2-P3	NO
L01XX71	TISAGENLECLEUCEL	In force	mentioned in the text	C2-P3	NO

History: entries into and exits from protocols

Month	Type	Code	Protocol	Level
March 2026	Medicine added	L01EL02	ACALABRUTINIBUM	mentioned in the text

Authorised brand products (ANMDM)

The Romanian register of medicines for human use, updated daily

Brand name	Form	Strength	Holder	ATC	Rx
BENDAMUSTINA ACCORD 2,5 mg/ml	PULB. PT. CONC. PT. SOL. PERF.	2,5mg/ml	ACCORD HEALTHCARE POLSKA SP. Z.O.O. - POLONIA	L01AA09	PR
BENDAMUSTINA ACCORD 25 mg/ml	CONC. PT. SOL. PERF.	25mg/ml	ACCORD HEALTHCARE POLSKA SP. Z.O.O. - POLONIA	L01AA09	PR
BENMAK 2,5 mg/ml	PULB. PT. CONC. PT. SOL. PERF.	2,5mg/ml	MAKPHARM D.O.O. - CROATIA	L01AA09	PR

Data extracted automatically from the documents published by CNAS (cnas.ro/protocoale-terapeutice) and from the ANMDM medicines register. For information only; the official text (the Ministry of Health / CNAS orders published in the Official Gazette) prevails. Protocol names and texts are shown in Romanian, as published.